# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-22-000042
Filing Date
2022-03-09
Accepted
2022-03-09 16:16:55
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | MODERNA, INC. - DEFA14A | lmrna2022_def14a.htm | DEFA14A | 7893
2 | GRAPHIC | box1.jpg | GRAPHIC | 1082
3 | GRAPHIC | checkbox1.jpg | GRAPHIC | 1317
4 | GRAPHIC | im2140623574x1773569987.jpg | GRAPHIC | 28148
5 | GRAPHIC | lmrna003_notice1.jpg | GRAPHIC | 335705
6 | GRAPHIC | lmrna003_notice2.jpg | GRAPHIC | 274235
| Complete submission text file | 0001308179-22-000042.txt |  | 891733

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38753 | Film No.: 22725562
SIC: 2836 Biological Products, (No Diagnostic Substances)